Vuno Inc is engaged in the business of manufacturing medical devices and equipment. The company develops and markets bone age testing equipment, brain quantification medical device, X-ray reading aid solutions, imaging devices, and other related devices.
2014
n/a
Last FY Revenue $17.5M
Last FY EBITDA -$7.4M
$180M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Vuno reported revenue of $17.5M and EBITDA of -$7.4M.
Vuno expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Vuno valuation multiples based on analyst estimates| NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|
| Revenue | XXX | $17.5M | XXX | XXX | XXX |
| Gross Profit | XXX | $17.0M | XXX | XXX | XXX |
| Gross Margin | XXX | 97% | XXX | XXX | XXX |
| EBITDA | XXX | -$7.4M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -42% | XXX | XXX | XXX |
| EBIT | XXX | -$8.4M | XXX | XXX | XXX |
| EBIT Margin | XXX | -48% | XXX | XXX | XXX |
| Net Profit | XXX | -$8.8M | XXX | XXX | XXX |
| Net Margin | XXX | -50% | XXX | XXX | XXX |
| Net Debt | XXX | $2.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Vuno has current market cap of KRW 280B (or $190M), and EV of KRW 266B (or $180M).
As of January 19, 2026, Vuno's stock price is KRW 19990 (or $14).
See Vuno trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $180M | $190M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialVuno's trades at 10.3x EV/Revenue multiple, and -24.3x EV/EBITDA.
See valuation multiples for Vuno and 15K+ public compsAs of January 19, 2026, Vuno has market cap of $190M and EV of $180M.
Equity research analysts estimate Vuno's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vuno's P/E ratio is not available.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $190M | XXX | $190M | XXX | XXX | XXX |
| EV (current) | $180M | XXX | $180M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 10.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -24.3x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -21.3x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -21.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -22.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialVuno's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Vuno's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Vuno's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Vuno and other 15K+ public comps| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 68% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 145% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vuno acquired XXX companies to date.
Last acquisition by Vuno was XXXXXXXX, XXXXX XXXXX XXXXXX . Vuno acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Vuno founded? | Vuno was founded in 2014. |
| Where is Vuno headquartered? | Vuno is headquartered in South Korea. |
| Is Vuno publicy listed? | Yes, Vuno is a public company listed on KRX. |
| What is the stock symbol of Vuno? | Vuno trades under 338220 ticker. |
| When did Vuno go public? | Vuno went public in 2021. |
| Who are competitors of Vuno? | Similar companies to Vuno include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Vuno? | Vuno's current market cap is $190M |
| Is Vuno profitable? | Yes, Vuno is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.